Human Albumin Dosing Guidelines
The recommended dose of human albumin varies by clinical indication, with 8 g/L of ascites removed for large-volume paracentesis (>5L) and 1.5 g/kg followed by 1 g/kg on day 3 for spontaneous bacterial peritonitis being the most evidence-based regimens. 1, 2
Dosing Recommendations by Clinical Indication
Large-Volume Paracentesis (>5L)
- Dose: 8 g albumin per liter of ascites removed 1, 2
- Administration timing: Immediately after paracentesis completion 2
- Formulation: 20% or 25% albumin solution 1
- Evidence strength: High quality evidence with strong recommendation 2, 3
Spontaneous Bacterial Peritonitis (SBP)
- Dose: 1.5 g/kg within 6 hours of diagnosis, followed by 1 g/kg on day 3 1, 4
- Target population: Particularly beneficial in patients with increased serum creatinine or rising serum creatinine 1
- Rationale: Reduces risk of renal dysfunction by 72% and mortality by 47% 1, 4
- Note: Some small studies suggest lower doses may be effective, but the standard regimen has the strongest evidence 1
Hepatorenal Syndrome (HRS-AKI)
- Dose: 20-40 g/day alongside vasoconstrictors 1
- Duration: Optimal duration remains unclear, but continued until response 1
- Administration: Intravenous infusion 1
Severe Burns
- Dose: 1-2 g/kg/day for patients with >30% total burned body surface area 1
- Timing: After the first 6 hours of management 1
- Target: Maintain albumin levels >30 g/L 1
- Rationale: Decreases crystalloid administration and resulting morbidity 1
Acute-on-Chronic Liver Failure (ACLF)
- Dose: 6-8 g/L of ascites removed regardless of volume 1, 2
- Special consideration: Albumin administration recommended even for paracentesis <5L in these high-risk patients 2
Administration Guidelines
Rate of Administration
- Administer slowly to prevent circulatory overload 2
- Monitor for signs of volume overload, especially in patients with cardiac dysfunction 2
Monitoring Parameters
- Hemodynamic parameters
- Signs of volume overload
- Renal function
- Electrolytes 2
Clinical Considerations and Pitfalls
Common Pitfalls
Overuse in non-indicated conditions: Albumin should not be used routinely for:
Potential adverse effects:
- Fluid overload
- Pulmonary edema
- Hypotension/tachycardia
- Pyrexia
- Rash/pruritus 1
Excessive dosing: Doses of HAS exceeding 87.5 g in SBP may be associated with worse outcomes due to fluid overload 1
Special Populations
- Pediatric burns patients: Early administration (8-12 hours post-burning) of 5% albumin decreases crystalloid requirements and fluid creep 1
- Patients with cardiac dysfunction: Require careful monitoring for volume overload 2
Conclusion
Human albumin dosing should be tailored to the specific clinical indication, with the strongest evidence supporting its use in large-volume paracentesis and spontaneous bacterial peritonitis. Administration should follow evidence-based protocols to maximize benefits while minimizing potential adverse effects.